SERUM INFLAMMATORY PROTEIN PROFILING TO CORROBORATE SELECTION OF THERAPY NAÏVE MODERATE-TO-SEVERE PAEDIATRIC CROHN’S DISEASE PATIENTS ELIGIBLE FOR FIRST-LINE INFLIXIMAB

Maria Myrthe Elisabeth Jongsma  1     Léa M. M. Costes  1     Irma Tindemans  1     Martinus A. Cozijnsen  1     H.C. Raatgeep  1     Merel van Pieterson  1     Yunlei Li  2     Johanna C. Escher  2     Lissy de Ridder  2     Janneke N Samsom  2    
1 Erasmus MC Sophia Children's Hospital, Rotterdam, Netherlands
2 Erasmus MC, Rotterdam, Netherlands

Topic
IBD, Immunology, Paediatrics

Session
IBD prediction and prognosis

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing